Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.

Hulleman E, Kazemier KM, Holleman A, VanderWeele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, Den Boer ML.

Blood. 2009 Feb 26;113(9):2014-21. doi: 10.1182/blood-2008-05-157842.

2.

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.

Appel IM, Kazemier KM, Boos J, Lanvers C, Huijmans J, Veerman AJ, van Wering E, den Boer ML, Pieters R.

Leukemia. 2008 Sep;22(9):1665-79. doi: 10.1038/leu.2008.165.

PMID:
18580955
3.

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group..

Blood. 2008 May 1;111(9):4477-89. doi: 10.1182/blood-2007-09-112920. Erratum in: Blood. 2009 Apr 30;113(18):4478. Dosage error in article text.

4.

Biology and treatment of acute lymphoblastic leukemia.

Pieters R, Carroll WL.

Pediatr Clin North Am. 2008 Feb;55(1):1-20, ix. doi: 10.1016/j.pcl.2007.11.002. Review.

PMID:
18242313
5.

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, Janka G, Rubnitz J, Silverman L, Stary J, Campbell M, Li CK, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi MG.

Lancet. 2007 Jul 21;370(9583):240-50.

PMID:
17658395
6.

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR.

Nature. 2007 Apr 12;446(7137):758-64.

PMID:
17344859
7.

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE, Eden TO, Vora AJ, Mitchell CD, Harrison CJ; UK Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Childhood Leukaemia Working Party (CLWP)..

Blood. 2007 Mar 15;109(6):2327-30.

8.

Bias in the estimation of false discovery rate in microarray studies.

Pawitan Y, Murthy KR, Michiels S, Ploner A.

Bioinformatics. 2005 Oct 15;21(20):3865-72. Erratum in: Bioinformatics. 2005 Dec 15;21(24):4435.

PMID:
16105901
9.

Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia.

van Delft FW, Bellotti T, Luo Z, Jones LK, Patel N, Yiannikouris O, Hill AS, Hubank M, Kempski H, Fletcher D, Chaplin T, Foot N, Young BD, Hann IM, Gammerman A, Saha V.

Br J Haematol. 2005 Jul;130(1):26-35.

PMID:
15982341
10.

Prediction of cancer outcome with microarrays: a multiple random validation strategy.

Michiels S, Koscielny S, Hill C.

Lancet. 2005 Feb 5-11;365(9458):488-92.

PMID:
15705458
11.

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

N Engl J Med. 2004 Aug 5;351(6):533-42.

12.

Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays.

Willenbrock H, Juncker AS, Schmiegelow K, Knudsen S, Ryder LP.

Leukemia. 2004 Jul;18(7):1270-7.

PMID:
15152267
13.

Acute lymphoblastic leukemia.

Pui CH, Relling MV, Downing JR.

N Engl J Med. 2004 Apr 8;350(15):1535-48. Review. No abstract available.

PMID:
15071128
14.

A global test for groups of genes: testing association with a clinical outcome.

Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC.

Bioinformatics. 2004 Jan 1;20(1):93-9.

PMID:
14693814
15.

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.

Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM.

Blood. 2004 Feb 1;103(3):1043-9.

16.

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.

J Clin Oncol. 2003 Sep 1;21(17):3262-8.

PMID:
12947061
17.

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.

Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR.

Blood. 2003 Oct 15;102(8):2951-9.

18.

Variance stabilization applied to microarray data calibration and to the quantification of differential expression.

Huber W, von Heydebreck A, Sültmann H, Poustka A, Vingron M.

Bioinformatics. 2002;18 Suppl 1:S96-104.

PMID:
12169536
19.

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR.

Cancer Cell. 2002 Mar;1(2):133-43.

20.
Items per page

Supplemental Content

Support Center